Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Sitagliptin/Simvastatin: a first combination tablet to treat type 2 diabetes and hypercholesterolemia--a review of its characteristics.

  • Authors : Ramadan WH; Department of Pharmacy Practice, School of Pharmacy, Lebanese American University, Byblos, Lebanon.; Kabbara WK

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/*therapeutic use ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/Hydroxymethylglutaryl-CoA Reductase Inhibitors/Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use

  • Source: Vascular health and risk management [Vasc Health Risk Manag] 2015 Feb 11; Vol. 11, pp. 125-32. Date of Electronic Publication: 2015 Feb 11 (Print Publication: 2015).Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101273479 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Utilisation of the isobole methodology to study dietary peptide-drug and peptide-peptide interactive effects on dipeptidyl peptidase IV (DPP-IV) inhibition.

  • Authors : Nongonierma AB; Department of Life Sciences and Food for Health Ireland (FHI), University of Limerick, Castletroy, Limerick, Ireland. .; FitzGerald RJ

Subjects: Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/*pharmacology ; Oligopeptides/Oligopeptides/Oligopeptides/*pharmacology ; Peptides/Peptides/Peptides/*pharmacology

  • Source: Food & function [Food Funct] 2015 Jan; Vol. 6 (1), pp. 313-20. Date of Electronic Publication: 2014 Dec 05.Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101549033 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Understanding the molecular dynamics of type-2 diabetes drug target DPP-4 and its interaction with Sitagliptin and inhibitor Diprotin-A.

  • Authors : Chakraborty C; School of Computer and Information Sciences, Galgotias University, Greater Noida, India.; Hsu MJ

Subjects: Molecular Dynamics Simulation*; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Dipeptidyl Peptidase 4/Dipeptidyl Peptidase 4/Dipeptidyl Peptidase 4/*metabolism

  • Source: Cell biochemistry and biophysics [Cell Biochem Biophys] 2014 Nov; Vol. 70 (2), pp. 907-22.Publisher: Humana Press Country of Publication: United States NLM ID: 9701934 Publication Model: Print Cited Medium: Internet ISSN: 1559-0283

Record details

×
Academic Journal

Sitagliptin: a review of its use in patients with type 2 diabetes mellitus.

  • Authors : Plosker GL; Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand, .

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/*therapeutic use ; Pyrazines/Pyrazines/Pyrazines/*therapeutic use

  • Source: Drugs [Drugs] 2014 Feb; Vol. 74 (2), pp. 223-42.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 7600076 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Restoration of the insulinotropic effect of glucose-dependent insulinotropic polypeptide contributes to the antidiabetic effect of dipeptidyl peptidase-4 inhibitors.

  • Authors : Aaboe K; Department of Endocrinology I, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.; Akram S

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/*therapeutic use ; Gastric Inhibitory Polypeptide/Gastric Inhibitory Polypeptide/Gastric Inhibitory Polypeptide/*metabolism

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2015 Jan; Vol. 17 (1), pp. 74-81. Date of Electronic Publication: 2014 Oct 26.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Effect of sitagliptin therapy on triglyceride-rich lipoprotein kinetics in patients with type 2 diabetes.

  • Authors : Tremblay AJ; Lipid Research Centre, Centre Hospitalier de l'Université Laval (CHUL) Research Centre, Quebec City, QC, Canada; Institute of Nutrition and Functional Foods, Laval University, Quebec City, QC, Canada.

Subjects: Blood Glucose/Blood Glucose/Blood Glucose/*drug effects ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/*pharmacology

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2014 Dec; Vol. 16 (12), pp. 1223-9. Date of Electronic Publication: 2014 Aug 19.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Effects of concomitant drugs on sitagliptin-mediated improvement in glycemic control in Japanese patients with type 2 diabetes.

  • Authors : Hirata T; Foundation for Biomedical Research and Innovation, Kobe, Japan. Electronic address: .; Inukai K

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/*therapeutic use ; Glycoside Hydrolase Inhibitors/Glycoside Hydrolase Inhibitors/Glycoside Hydrolase Inhibitors/*therapeutic use

  • Source: Primary care diabetes [Prim Care Diabetes] 2014 Oct; Vol. 8 (3), pp. 265-70. Date of Electronic Publication: 2014 Feb 14.Publisher: Elsevier Country of Publication: England NLM ID: 101463825 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0210

Record details

×
Academic Journal

The dipeptidyl peptidase-4 inhibitor sitagliptin protects against dyslipidemia-related kidney injury in Apolipoprotein E knockout mice.

  • Authors : Li J; Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou 510150, China. .; Guan M

Subjects: Acute Kidney Injury/Acute Kidney Injury/Acute Kidney Injury/*drug therapy ; Apolipoproteins E/Apolipoproteins E/Apolipoproteins E/*genetics ; Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/*therapeutic use

  • Source: International journal of molecular sciences [Int J Mol Sci] 2014 Jun 26; Vol. 15 (7), pp. 11416-34. Date of Electronic Publication: 2014 Jun 26.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
  • 1-10 of  389 results for ""PYRAZINES""